What is the recommended intravenous (IV) dose of vitamin B12?

Recommended Intravenous Dose of Vitamin B12

The FDA-approved intravenous route for vitamin B12 is not recommended, as almost all of the vitamin will be lost in the urine; intramuscular or deep subcutaneous injection is the preferred parenteral route. 1

Critical Caveat About IV Administration

The FDA drug label explicitly states to avoid using the intravenous route because it results in almost complete urinary excretion of the vitamin, making it therapeutically ineffective. 1 When parenteral administration is necessary, intramuscular (IM) or deep subcutaneous injection should be used instead. 1

Recommended Parenteral Dosing (IM/Subcutaneous)

For Vitamin B12 Deficiency with Neurological Involvement

• Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement, then 1 mg IM every 2 months for maintenance. 2
• This aggressive regimen is essential because neurological damage can become irreversible if not treated promptly. 2
• Urgent specialist consultation with neurology and hematology is required for any suspected neurological involvement. 2

For Vitamin B12 Deficiency without Neurological Involvement

• Hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by maintenance therapy of 1 mg IM every 2-3 months for life. 2
• The FDA label suggests an alternative regimen: 100 mcg daily for 6-7 days IM/subcutaneous, then alternate days for seven doses, then every 3-4 days for 2-3 weeks, followed by 100 mcg monthly for life. 1

For Pernicious Anemia

• 100 mcg daily for 6-7 days by intramuscular or deep subcutaneous injection, followed by the same amount on alternate days for seven doses, then every 3-4 days for another 2-3 weeks, then 100 mcg monthly for life. 1
• However, the more recent British guidelines recommend the higher 1 mg dose regimen described above. 2

For Bariatric Surgery Patients with Deficiency

• 1000-2000 mcg/day sublingual, intramuscular, or 3000 mcg every 6 months intramuscularly after RYGB and BPD procedures. 2
• IM or subcutaneous B12 is necessary when oral therapy fails to correct deficiency. 2

Special Clinical Contexts

For Pralatrexate-Induced Mucositis Prevention

• Vitamin B12 (cyanocobalamin) 1000 mcg intramuscularly, started no more than 10 weeks prior to pralatrexate therapy and repeated every 8-10 weeks. 2

For Hyperammonemia Management (Pediatric)

• Vitamin B12 1 mg IV as part of the medical management protocol for hyperammonemia. 2
• This is one of the rare contexts where IV administration is specifically recommended in guidelines.

Research Evidence on Dosing

Studies in hemodialysis patients have used 1000 mcg (1 mg) IV weekly for vitamin B12 supplementation, though this was primarily for research purposes rather than standard clinical practice. 3, 4, 5 One study found that IV B12 at 1 mg weekly was as effective as low-dose folinic acid in correcting hyperhomocysteinemia. 4 Another study used high-dose IV B-complex vitamins (including B12 1.5 mg) three times weekly post-dialysis. 6

Important Clinical Pitfalls

• Never administer folic acid before treating B12 deficiency, as this can mask the anemia while allowing irreversible neurological damage to progress (subacute combined degeneration of the spinal cord). 2, 1
• The 1000 mcg dose retains significantly more vitamin than 100 mcg doses, with no disadvantage in cost or toxicity, making it the preferred maintenance dose. 7
• Patients with pernicious anemia require lifelong monthly injections; failure to continue treatment will result in return of anemia and irreversible nerve damage. 1
• Serum potassium must be monitored closely during the first 48 hours of treatment and replaced if necessary. 1